Stockreport

BioCardia Announces Pricing of $10.0 Million Public Offering and Uplisting to Nasdaq

BioCardia, Inc.  (BCDA) 
PDF SAN CARLOS, Calif., Aug. 02, 2019 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NasdaqCM: BCDA, BCDAW), a leader in the development of comprehensive solutions for cardiovascula [Read more]